Efficacy of Electronic Cigarettes for Smoking Cessation

Orr, Katherine Kelly; Asal, Nicole J.

doi:10.1177/1060028014547076

Cited by 35 publications

(29 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We were not able to determine if substitution of e-cigarettes for tobacco cigarettes played a direct role in the reduced number of cigarettes smoked per day among smokers and in the overall reduced smoking rates reported from 2008 to 2014. Studies show that e-cigarette use as a cessation strategy among smokers is on the rise [29] though the efficacy of e-cigarettes in smoking cessation is unclear as is their long-term safety [30]. …”

Section: Discussionmentioning

confidence: 99%

Massachusetts Medicaid members that smoked in 2008: Characteristics associated with smoking status in 2014

et al. 2017

View full text Add to dashboard Cite

The smoking rate among non-elderly Medicaid enrollees is more than double the rate for those privately insured; smoking-related conditions account for 15% of Medicaid expenditures. Under state health reform, Massachusetts Medicaid (MassHealth) made tobacco cessation treatment available beginning in 2006. We used surveys conducted in 2008 and 2014 to examine changes in smoking abstinence rates among MassHealth members identified as smokers and to identify factors associated with being a former smoker. Members previously identified as smokers were surveyed by mail or phone; 2008 and 2014 samples included 3,116 and 2,971 members, respectively. Surveys collected demographic and health information, asked members whether they smoked cigarettes "every day, some days or not at all', and asked questions to assess smoking intensity among current smokers. The 2014 survey included an open ended-question asking members "what helped the most" in quitting or quit attempts. We observed a significant decrease in members reporting smoking "every/ some days" of 15.5 percentage points (p < .0001) from 2008 to 2014, and a significant decrease in smokers reporting smoking "more than 10 cigarettes on days smoked" of 16.7 percentage points (p < .0001). Compared to smokers, former smokers more frequently reported health concerns, the influence of family members, and the use of e-cigarettes as helping the most in quitting. Expanded access to tobacco cessation treatment under the Affordable Care Act may have help to reduce the high smoking rates among Medicaid enrollees. Additionally, smokers' concerns about health and the influence of family and friends provide opportunities for targeted intervention and messaging about quitting.

show abstract

Section: Discussionmentioning

confidence: 99%

Massachusetts Medicaid members that smoked in 2008: Characteristics associated with smoking status in 2014

et al. 2017

View full text Add to dashboard Cite

show abstract

“…nicotine patch/gum, bupropion SR, and varenicline are approved by the FDA for smoking cessation. This however, is not the case for e-cigarettes (despite the popular belief) since the rather scarce and quite contradictory scientific evidences do not presently justify their use as smoking cessation tools (Orr and Asal, 2014). …”

Section: The Success Of E-cigarette In Smoking Cessation Programmentioning

confidence: 99%

A decade of e-cigarettes: Limited research & unresolved safety concerns

et al. 2016

View full text Add to dashboard Cite

It is well known that tobacco consumption is a leading cause of preventable deaths worldwide and has been linked to major diseases ranging from cancer to chronic obstructive pulmonary disease, atherosclerosis, stroke and a host of neurological/neurodegenerative disorders. In the past decade a number of alternative vaping products have hit the market, rapidly gaining consumers especially among the younger population. Electronic nicotine delivery systems or e-cigarettes have become the sought-after product due to the belief that they are much safer than traditional cigarettes. However, inadequate research and lack of regulatory guidelines for both the manufacturing process and the content of the vaping solution of the e-cigarette has become a major concern. Highly debated and unresolved questions such as whether e-cigarettes may help smokers quit and whether e-cigarettes will promote the use of nicotine among non-smokers add to the confusion of the safety of e-cigarettes. In this review article, we summarize the current understanding (and lack thereof) of the potential health impacts of e-cigarettes. We will also highlight the most recent studies (in vivo/in vitro) which seem to conflict with the broad safety claims put forward by the manufacturers. Finally, we provide potential solutions to overcome the research gap of the short and long-term health impact of e-cigarettes.

show abstract

“…Çalışmaların çoğunda kısa süreli takip söz konusu ve uzun süreli gerçek bırakma oranları yoktur (29) . E-sigara ile bırakma denemeleri, nikotin replasman tedavisine üstünlüğünün olmadığını göstermiş olup, e-sigara kullanımı genellikle daha az sigara bırakma oranlarıyla birliktedir (3,30) .…”

Section: E-sigara Sigara Bıraktırır Mı?unclassified

Electronic Cigarette

Özlü¹

2017

GGHS

View full text Add to dashboard Cite

Efficacy of Electronic Cigarettes for Smoking Cessation

Cited by 35 publications

References 9 publications

Massachusetts Medicaid members that smoked in 2008: Characteristics associated with smoking status in 2014

Massachusetts Medicaid members that smoked in 2008: Characteristics associated with smoking status in 2014

A decade of e-cigarettes: Limited research & unresolved safety concerns

Electronic Cigarette

Contact Info

Product

Resources

About